Skip to main content
$265.79 -$0.40 (-0.2%)

04:00 PM EDT on 04/14/21

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 4 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $265.79 Mkt Cap $40.1B
Open $267.44 P/E Ratio 10.71
Prev. Close $266.19 Div. (Yield) $0.00 (0.0%)
Daily Range $264.63 - $270.38 Volume 697,418
52-Wk Range $223.25 - $363.92 Avg. Daily Vol. 1,174,630

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

971 Outperform
71 Underperform
 

All-Star Players

210 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (98.31)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (23.93)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar rocker20 (< 20) Submitted: 12/8/2020 8:12:47 AM : Outperform Start Price: $246.30 NASDAQ:BIIB Score: -3.98

strong historical performer with good ROIC

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 11/9/2020 4:56:02 PM : Outperform Start Price: $241.67 NASDAQ:BIIB Score: -6.40

Strong portfolio of Alzheimer's disease projects that don't have correlates anywhere else in the market. Demonstrated history of innovating within a difficult space.

Recs

0
Member Avatar TMFjimhalley (52.16) Submitted: 11/8/2020 6:57:33 AM : Outperform Start Price: $230.00 NASDAQ:BIIB Score: +2.52

All of these stocks are likely to go down in the short term because of the negative news coming out of the FDA advisory committee regarding aducanumab.

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (93.15) Score: +637.71

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey < 20 4/12/2007 Outperform 3Y $43.64 +509.05% +202.63% +306.43 1 Comment
tradersinsights 55.64 4/10/2007 Outperform 1Y $44.42 +498.36% +201.02% +297.34 1 Comment
anewday101 90.17 3/5/2007 Outperform 1Y $43.36 +512.98% +216.63% +296.35 0 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +504.76% +210.06% +294.69 0 Comment
mtung 36.67 3/8/2007 Outperform NS $44.10 +502.70% +210.74% +291.96 0 Comment
nickysone 57.50 4/9/2007 Outperform 3Y $44.86 +492.49% +200.73% +291.76 1 Comment
mgroeber < 20 4/9/2007 Outperform NS $44.86 +492.49% +200.73% +291.76 0 Comment
Actionman2go 63.81 4/13/2007 Outperform 3Y $45.00 +490.64% +200.40% +290.25 1 Comment
apple1jam 71.11 3/6/2007 2/27/2008 Outperform NS $43.94 +504.89% +214.68% +290.22 0 Comment
tlop1 < 20 5/18/2007 Outperform 3Y $46.51 +471.47% +186.16% +285.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.